Abstract:Background: The Polycomb group (PcG) of proteins is a family of important developmental regulators. The respective members function as large protein complexes involved in establishment and maintenance of transcriptional repression of developmental control genes. MBTD1, Malignant Brain Tumor domain-containing protein 1, is one such PcG protein. MBTD1 contains four MBT repeats. Methodology/principal findings: We have determined the crystal structure of MBTD1 (residues 130-566aa covering the 4 MBT repeats) at 2.5 A resolution by X-ray crystallography. The crystal structure of MBTD1 reveals its similarity to another four-MBT-repeat protein L3MBTL2, which binds lower methylated lysine histones. Fluorescence polarization experiments confirmed that MBTD1 preferentially binds mono- and di-methyllysine histone peptides, like L3MBTL1 and L3MBTL2. All known MBT-peptide complex structures characterized to date do not exhibit strong histone peptide sequence selectivity, and use a "cavity insertion recognition mode" to recognize the methylated lysine with the deeply buried methyl-lysine forming extensive interactions with the protein while the peptide residues flanking methyl-lysine forming very few contacts [1]. Nevertheless, our mutagenesis data based on L3MBTL1 suggested that the histone peptides could not bind to MBT repeats in any orientation. Conclusions: The four MBT repeats in MBTD1 exhibits an asymmetric rhomboid architecture. Like other MBT repeat proteins characterized so far, MBTD1 binds mono- or dimethylated lysine histones through one of its four MBT repeats utilizing a semi-aromatic cage. Enhanced version: This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.

A BTB extension and ion-binding domain contribute to the pentameric structure and TFAP2A binding of KCTD1

Positioning of the First Extracellular Loop of CFTR Has Significant Effects on CFTR Gating

Structural studies of KCTD1 and its disease-causing mutant P20S provide insights into the protein function and misfunction

Characterization and Expression of A Human Kctd1 Gene Containing the Btb Domain, Which Mediates Transcriptional Repression and Homomeric Interactions

The Tetramerization Domain Potentiates Kv4 Channel Function by Suppressing Closed-State Inactivation.

Two Distinct Functions for the BTB Domain of the CD4-differentiating Factor Thpok (85.20)

Identification of a Tetrameric Assembly Domain in the C Terminus of Heat-Activated TRPV1 Channels.

BTB domain mutations perturbing KCTD15 oligomerisation cause a distinctive frontonasal dysplasia syndrome

Pentameric Assembly of the Kv2.1 Tetramerization Domain

The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation.

A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3

Structural basis for specific DNA sequence motif recognition by the TFAP2 transcription factors

Expression, Purification, and Secondary Structure Characterization of Recombinant KCTD1

The C-terminus of CFAP410 forms a tetrameric helical bundle that is essential for its localization to the basal body

Structural basis of beta-catenin recognition by Tax-interacting protein-1.

Crystal structure of the ubiquitin-like domain of human TBK1

Structural studies of a four-MBT repeat protein MBTD1

A complex CTCF binding code defines TAD boundary structure and function

Structure and Ubiquitination-Dependent Activation of Tank-Binding Kinase 1

Structural Basis of β-Catenin Recognition by Tax-interacting Protein-1

Structural Characterization of DNA Binding Domain of Essential Mammalian Protein TTF 1